Haemodynamic profiles of children with end-stage heart failure

被引:28
|
作者
Chen, Sharon [1 ]
Dykes, John C. [1 ]
McElhinney, Doff B. [1 ]
Gajarski, Robert J. [2 ]
Shin, Andrew Y. [1 ]
Hollander, Seth A. [1 ]
Everitt, Melanie E. [3 ]
Price, Jack F. [4 ]
Thiagarajan, Ravi R. [5 ]
Kindel, Steven J. [6 ]
Rossano, Joseph W. [7 ]
Kaufman, Beth D. [1 ]
May, Lindsay J. [8 ]
Pruitt, Elizabeth [9 ]
Rosenthal, David N. [1 ]
Almond, Christopher S. [1 ]
机构
[1] Stanford Univ, 750 Welch Rd,Suite 305, Palo Alto, CA 94304 USA
[2] Nationwide Childrens Hosp, Columbus, OH USA
[3] Childrens Hosp Colorado, Aurora, CO USA
[4] Texas Childrens Hosp, Houston, TX 77030 USA
[5] Boston Childrens Hosp, Boston, MA USA
[6] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
[7] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[8] Primary Childrens Med Ctr, Salt Lake City, UT USA
[9] Univ Alabama Birmingham, Pediat Heart Transplant Study Grp, Birmingham, AL USA
关键词
Paediatric heart failure; Haemodynamics; IN-HOSPITAL MORTALITY; MEDICAL-MANAGEMENT; VENOUS CONGESTION; FILLING PRESSURES; TRANSPLANTATION; OUTCOMES; THERAPY; ASSOCIATION; DIAGNOSIS; SOCIETY;
D O I
10.1093/eurheartj/ehx456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To evaluate associations between haemodynamic profiles and symptoms, end-organ function and outcome in children listed for heart transplantation. Methods and results Children <18 years listed for heart transplant between 1993 and 2013 with cardiac catheterization data [pulmonary capillary wedge pressure (PCWP), right atrial pressure (RAP), and cardiac index (CI)] in the Pediatric Heart Transplant Study database were included. Outcomes were New York Heart Association (NYHA)/Ross classification, renal and hepatic dysfunction, and death or clinical deterioration while on waitlist. Among 1059 children analysed, median age was 6.9 years and 46% had dilated cardiomyopathy. Overall, 58% had congestion (PCWP>15mmHg), 28% had severe congestion (PCWP>22mmHg), and 22% low cardiac output (CI<2.2 L/min/m(2)). Twenty-one per cent met the primary outcome of death (9%) or clinical deterioration (12%). In multivariable analysis, worse NYHA/Ross classification was associated with increased PCWP [odds ratio (OR) 1.03, 95% confidence interval (95% CI) 1.01-1.07, P=0.01], renal dysfunction with increased RAP (OR 1.04, 95% CI 1.01-1.08, P=0.007), and hepatic dysfunction with both increased PCWP (OR 1.03, 95% CI 1.01-1.06, P < 0.001) and increased RAP (OR 1.09, 95% CI 1.06-1.12, P < 0.001). There were no associations with low output. Death or clinical deterioration was associated with severe congestion (OR 1.6, 95% CI 1.2-2.2, P=0.002), but not with CI alone. However, children with both low output and severe congestion were at highest risk (OR 1.9, 95% CI 1.1-3.5, P=0.03). Conclusion Congestion is more common than low cardiac output in children with end-stage heart failure and correlates with NYHA/Ross classification and end-organ dysfunction. Children with both congestion and low output have the highest risk of death or clinical deterioration.
引用
收藏
页码:2900 / 2909
页数:10
相关论文
共 50 条
  • [31] Hemodynamic Findings Associated with End-Organ Dysfunction in Children with End-Stage Heart Failure
    Chen, S.
    McElhinney, D. B.
    Dykes, J. C.
    Rosenthal, D. N.
    Hollander, S. A.
    Maeda, K.
    Jensen, K.
    Yarlagadda, V. V.
    Ford, M. A.
    Price, J. F.
    Almond, C. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S414 - S414
  • [32] Skeletal Muscle Index and Malnutrition in Children With End-Stage Heart Failure Awaiting Heart Transplant
    Schultz, Lisa M.
    Larson, David
    Isaacson, Jared
    Dennis, Katelin
    Rosenthal, David N.
    Dykes, John C.
    Liu, Esther
    Zhang, Yulin
    McElhinney, Doff B.
    Almond, Christopher S.
    CIRCULATION, 2017, 136
  • [33] Haemodynamic assessment of multisite ventricular pacing by peak endocardial acceleration and echocardiography in patients with end-stage heart failure
    Garrigue, S
    Gencel, L
    Bordachar, P
    Reuter, S
    Kobeissi, A
    Gaggini, G
    Clementy, J
    EUROPEAN HEART JOURNAL, 2000, 21 : 191 - 191
  • [34] End-stage heart failure: The future of heart transplant and artificial heart
    Bounader, Karl
    Flecher, Erwan
    PRESSE MEDICALE, 2024, 53 (01):
  • [35] Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist
    Severino, Paolo
    Mather, Paul J.
    Pucci, Mariateresa
    D'Amato, Andrea
    Mariani, Marco Valerio
    Infusino, Fabio
    Birtolo, Lucia Ilaria
    Maestrini, Viviana
    Mancone, Massimo
    Fedele, Francesco
    DIAGNOSTICS, 2019, 9 (04)
  • [36] When the failing, end-stage heart is not end-stage
    Renlund, Dale G.
    Kfoury, Abdallah G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (18): : 1922 - 1925
  • [37] Antiendomysial antibodies in patients with end-stage heart failure
    Prati, D
    Bardella, MT
    Peracchi, M
    Porretti, L
    Scalamogna, M
    Conte, D
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (01): : 218 - 219
  • [38] Inotropic therapy for end-stage heart failure patients
    Toma M.
    Starling R.C.
    Current Treatment Options in Cardiovascular Medicine, 2010, 12 (5) : 409 - 419
  • [39] Peritoneal ultrafiltration in end-stage chronic heart failure
    Froehlich, Hanna
    Katus, Hugo A.
    Taeger, Tobias
    Lossnitzer, Nicole
    Grossekettler, Leonie
    Kihm, Lars
    Zeier, Martin
    Remppis, Andrew
    Frankenstein, Lutz
    Schwenger, Vedat
    CLINICAL KIDNEY JOURNAL, 2015, 8 (02): : 219 - 225
  • [40] Dynamic cardiomyoplasty in patients with end-stage heart failure
    Elencwajg, B
    Trainini, J
    Roncoroni, A
    Griotti, J
    Jaimes, F
    Amor, R
    Schalet, H
    Moreno, S
    Perez, R
    Barisani, J
    XIII WORLD CONGRESS OF CARDIOLOGY: FREE PAPERS, 1998, : 605 - 608